Neuroacoustic Software – NuCalm’s® interview with Jim Poole, President/CEO


Tonight, New to The Street’s TV, Jane King interviews Jim Poole, President/CEO at NuCalm®. From the Nasdaq MarketSite studio, Jim talks about the Company’s patented, clinically proven neuroscience technology that addresses brain circuitry. The neuroacoustic software technology platforms reduce stress, improve sleep, and increase performance. Jim explains the science behind NuCalm, and how Dr. Blake Holloway discovered and developed the neuroacoustical sound wave technology after many years of research. Using alpha and theta transmissions, played through music on a headset, end-users enjoy improvements in sleep and reduce stress. Until now, the cost was too high for most to enjoy the platforms. The Company worked diligently to change its FDA designation from a Class -III medical device to a consumer product, a successful change that now makes the application available to many. From 2009 to 2015, the Company had about 9,000 clients. But now, with the new designation, the Company has over 91,000 clients and growing. Military personnel, sports stars, doctors, and others enjoy the NuCalm, which is simple and affordable. For a non-drug related solution to stress, sleep, and other performance issues, clinical studies prove NuCalm works to change the brain waves frequencies for positive outcomes. The on-screen QR code is available during the show; download or visit NuCalm® –

To make sure you never miss a video from New to the Street, click here to subscribe:

Follow New to the Street on Twitter:

Follow New to the Street on Facebook:

Follow New to the Street on Instagram:

Follow New to the Street on Rumble:

About New to the Street:

Subscribe to our Mailing List: